Osteoarthritis Injectable Market
The global Osteoarthritis Injectable Market size was valued at USD 8,624.8 million in 2025 and is projected to reach USD 17,664.8 million by 2035, expanding at a CAGR of 7.43% from 2026 to 2035.
Market Overview
The global Osteoarthritis Injectable Market is experiencing steady growth, driven by the increasing prevalence of osteoarthritis, an aging population, and rising demand for minimally invasive treatment options. Osteoarthritis is a degenerative joint condition that affects mobility, causes chronic pain, and reduces quality of life. Injectable therapies are increasingly being used to manage symptoms, improve joint function, and potentially delay surgical interventions.
According to BrandEssence Market Research, the market is supported by the growing adoption of hyaluronic acid injections, corticosteroids, platelet-rich plasma (PRP), and other regenerative injectable therapies. Increasing investments in orthopedic healthcare, advancements in intra-articular treatment techniques, and expanding research into disease-modifying osteoarthritis drugs are also creating growth opportunities. In 2025, North America accounted for the largest regional market share of 55.3%, while hyaluronic acid injections represented the leading injectable type with a 42.8% share.
Download Free Sample Report: Osteoarthritis Injectable Market – Request a Free Sample
Growth Drivers & Trends
The rising global burden of osteoarthritis is a major factor driving market expansion. Increasing life expectancy and age-related joint degeneration are contributing to a growing patient population requiring effective pain management and mobility support.
Another important growth driver is the preference for minimally invasive treatments. Patients and healthcare providers are increasingly considering injectable therapies as alternatives to more invasive procedures. Hyaluronic acid and corticosteroid injections remain important treatment options, while PRP and other regenerative therapies are attracting interest because of their potential applications in joint preservation.
Technological advancements in image-guided injections, long-acting formulations, and regenerative medicine are further supporting market development. However, inconsistent clinical evidence for certain biologic therapies, high treatment costs, and limited reimbursement coverage remain important market challenges.
Market Segmentation
The Osteoarthritis Injectable Market is segmented by injectable type, anatomy, and end user.
- By Injectable Type: Hyaluronic acid injections, corticosteroid injections, platelet-rich plasma (PRP) injections, placental tissue matrix (PTM) injections, acetylsalicylic acid (ASA) injections, and others. Hyaluronic acid injections dominated with a 42.8% market share in 2025, while PRP injections are expected to experience the fastest growth.
- By Anatomy: Knee osteoarthritis, hip osteoarthritis, hand osteoarthritis, and others. Knee osteoarthritis accounted for the largest share of 71.9% in 2025.
- By End User: Hospital pharmacies, retail pharmacies, and others. Hospital pharmacies held the leading position, supported by hospital-based injectable procedures and access to specialized orthopedic care.
Regional Analysis
North America dominated the global Osteoarthritis Injectable Market in 2025, accounting for 55.3% of the total market and generating approximately USD 4,769.5 million. Strong orthopedic healthcare infrastructure, favorable reimbursement policies, and widespread adoption of injectable therapies support regional growth.
Europe represented approximately USD 1,897.4 million in 2025. Increasing geriatric populations, established healthcare systems, and growing demand for conservative osteoarthritis management are supporting market expansion.
Asia Pacific is expected to experience significant growth during the forecast period. Rising awareness of osteoarthritis treatments, expanding healthcare infrastructure, increasing healthcare expenditure, and a growing elderly population are creating opportunities for injectable therapy manufacturers.
Latin America and the Middle East & Africa are also expected to witness market development, supported by improving access to healthcare services and increasing demand for orthopedic treatments.
Competitive Landscape
The global Osteoarthritis Injectable Market is characterized by competition among pharmaceutical companies, biotechnology manufacturers, and orthopedic healthcare solution providers. Market participants are focusing on product innovation, clinical research, strategic collaborations, and portfolio expansion to strengthen their competitive positions.
The increasing development of regenerative injectable therapies, advanced hyaluronic acid formulations, and minimally invasive treatment solutions is influencing competitive strategies. Companies are also focusing on improving treatment accessibility, strengthening distribution networks, and expanding their presence across emerging healthcare markets.
Get the Complete Market Report – Buy Now: Osteoarthritis Injectable Market Report
Key Players
Major companies operating in the global Osteoarthritis Injectable Market include:
- Anika Therapeutics, Inc.
- Bioventus
- Ferring Pharmaceuticals Inc.
- Sanofi S.A.
- Flexion Therapeutics, Inc.
- Zimmer Biomet
- Arthrex, Inc.
- Royal Biologics
- Teva Pharmaceutical Industries Ltd.
These companies are focusing on injectable product development, research investments, clinical advancements, and strategic business initiatives to strengthen their market presence.
Recent Developments
- Increasing research into platelet-rich plasma (PRP) and regenerative injectable therapies is expanding the range of treatment approaches for osteoarthritis.
- Advancements in image-guided injection techniques are supporting more targeted intra-articular treatment procedures.
- Growing interest in disease-modifying osteoarthritis drugs (DMOADs) is encouraging pharmaceutical and biotechnology companies to explore therapies beyond conventional symptom management.
- Development of long-acting injectable formulations and innovative biologic products is creating new opportunities for market participants.
- Increasing clinical research into combination therapies and cartilage-preserving approaches is contributing to the evolving osteoarthritis treatment landscape.
Frequently Asked Questions (FAQs)
- What is the global Osteoarthritis Injectable Market size?
The global Osteoarthritis Injectable Market was valued at USD 8,624.8 million in 2025 and is projected to reach USD 17,664.8 million by 2035.
- What is the expected CAGR of the Osteoarthritis Injectable Market?
The market is expected to expand at a CAGR of 7.43% during the forecast period from 2026 to 2035.
- What are the major factors driving market growth?
The major growth drivers include increasing osteoarthritis prevalence, aging populations, growing demand for minimally invasive treatments, advancements in regenerative medicine, and rising adoption of injectable therapies.
- Which segment dominates the Osteoarthritis Injectable Market?
Hyaluronic acid injections dominated the injectable type segment with a 42.8% market share in 2025. Knee osteoarthritis was the leading anatomy segment, accounting for 71.9%.
- Which region holds the largest share of the Osteoarthritis Injectable Market?
North America dominated the global market in 2025, accounting for 55.3% of the total market share, supported by advanced orthopedic healthcare infrastructure and increasing adoption of injectable treatments.
About Us
At BrandEssence®, we help companies enhance their strategies by providing actionable insights. We use scientific research to investigate consumer views, perceptions, and expectations regarding an existing or proposed product or service launch. A variety of factors influence the success of a product and service launch, and scientific research helps organizations understand opinions, perceptions, and expectations. The team at BrandEssence® applies market research methodologies across industries and domains, using research tools and analytical approaches to generate actionable market insights.
Contact US
BrandEssence® Market Research and Consulting Pvt ltd
Phone No.: +918975852287
Email Id: sales@brandessenceresearch.com
Website link: https://brandessenceresearch.com/
